Among other tissues, GLP-1 receptors are expressed in the lungs and exhibit anti-inflammatory properties by reducing circulating inflammatory markers thereby reducing COPD morbidity and mortality in mice and among patients, GLP-1 RA reduce respiratory diseases including COPD exacerbations [3, 4]. The gene discussed is GLP1R; the disease is chronic obstructive pulmonary disease.